199102-74-4

Basic information

• Product Name: 2-amino-5-(4-chlorobenzoyl)-3-(3,4-dimethoxybenzoyl)-4,5,6,7-tetrahydro-thieno[3,2-c]pyridine
• Synonyms: 2-amino-5-(4-chlorobenzoyl)-3-(3,4-dimethoxybenzoyl)-4,5,6,7-tetrahydro-thieno[3,2-c]pyridine
• CAS NO: 199102-74-4
• Molecular Weight: 456.95
• Mol File: 199102-74-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-amino-5-(4-chlorobenzoyl)-3-(3,4-dimethoxybenzoyl)-4,5,6,7-tetrahydro-thieno[3,2-c]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-amino-5-(4-chlorobenzoyl)-3-(3,4-dimethoxybenzoyl)-4,5,6,7-tetrahydro-thieno[3,2-c]pyridine(199102-74-4)
• EPA Substance Registry System: 2-amino-5-(4-chlorobenzoyl)-3-(3,4-dimethoxybenzoyl)-4,5,6,7-tetrahydro-thieno[3,2-c]pyridine(199102-74-4)

Safety Data

• Hazardous Substances Data: 199102-74-4(Hazardous Substances Data)

Upstream product

• 4640-69-1 ω-cyano-3,4-dimethoxyacetophenone 

Downstream Products

• 199102-75-5 ethyl 6-(4-chlorobenzoyl)-2-chloromethyl-4-(3,4-dimethoxyphenyl)-5,6,7,8-tetrahydrothieno[2,3-b:4,5-c']dipyridine-3-carboxylate 
• 199102-01-7 ethyl 6-(4-chlorobenzoyl)-2-diethylaminomethyl-4-(3,4-dimethoxyphenyl)-5,6,7,8-tetrahydrothieno[2,3-b:4,5-c']dipyridine-3-carboxylate 
• 199102-02-8 ethyl 2-(diethylaminomethyl)-4-(3,4-dimethoxyphenyl)-5,6,7,8-tetrahydrothieno[2,3-b:4,5-c']dipyridine-3-carboxylate 

Relevant articles and documents

Thienopyridine derivatives and their use

PCT No. PCT/JP97/01413 Sec. 371 Date Jun. 26, 1997 Sec. 102(e) Date Jun. 26, 1997 PCT Filed Apr. 23, 1997 PCT Pub. No. WO97/40050 PCT Pub. Date Oct. 30, 1997There is disclosed a compound of the formula (A): wherein W is C-G or C-G' (G is optionally esterified carboxyl; and G' is halogen); X is oxygen, optionally oxidized sulfur or -(CH2)q- (q is 0 to 5); R is optionally substituted amino or heterocyclic group; the ring B is optionally substituted nitrogen-containing 5- to 7-membered ring; L is hydrogen, optionally substituted hydrocarbon residue, optionally substituted acyl, optionally substituted carbamoyl, optionally substituted thiocarbamoyl or optionally substituted sulfonyl provided that, when W is C-G, L is hydrogen, optionally substituted acyl, optionally substituted carbamoyl, optionally substituted alkoxycarbonyl, optionally substituted thiocarbamoyl or optionally substituted sulfonyl; n is 0 or 1; the ring A may have a substituent. A process for producing the compound (A) and a pharmaceutical composition containing the compound (A) are also disclosed. The pharmaceutical composition is useful for an anti-inflammatory drug, particularly, a drug for preventing or treating arthritis, a drug for inhibiting bone resorption, immunosuppressant or the like.